Emcure Pharmaceuticals has appointed Ms. Amruta Jana Yangalwar as the Company Secretary and Compliance Officer, effective February 04, 2026. Ms. Yangalwar, an ICSI member (Membership No. A25687), brings over 16 years of post-qualification experience to the role. This appointment was approved by the Board of Directors at their meeting held on February 4, 2026.
Key Leadership Addition
Emcure Pharmaceuticals Limited announced the appointment of Ms. Amruta Jana Yangalwar as Company Secretary and Compliance Officer. This appointment is effective from February 04, 2026, as decided during the Board of Directors meeting held on the same day.
Professional Background
Ms. Yangalwar is a qualified professional holding an ICSI Membership (No. A25687). Her expertise covers a wide range of corporate secretarial functions. She possesses over 16 years of experience in corporate secretarial practice and regulatory compliance.
Meeting Conclusion
The Board of Directors meeting, during which this appointment was formalized, commenced at 12:40 p.m. (IST) and concluded at 1:15 p.m. (IST) on February 04, 2026.
Source: BSE
